Beyond fasting plasma glucose: the association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults. 2013

Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
Stanford University School of Medicine Stanford, CA 94305, USA. slbhat@stanford.edu

OBJECTIVE Prediabetes is defined by elevations of plasma glucose concentration, and is aimed at identifying individuals at increased risk of type 2 diabetes and coronary heart disease (CHD). However, since these individuals are also insulin resistant and hyperinsulinemic, we evaluated the association between several facets of carbohydrate metabolism and CHD risk profile in apparently healthy, nondiabetic individuals. METHODS Plasma glucose and insulin concentrations were measured before and at hourly intervals for eight hours after two test meals in 281 nondiabetic individuals. Insulin action was quantified by determining the steady-state plasma glucose (SSPG) concentration during the insulin suppression test. CHD risk was assessed by measurements of blood pressure and fasting lipoprotein profile. RESULTS For purposes of analysis, the population was divided into tertiles, and the results demonstrated that the greater the 1) fasting plasma glucose (FPG) concentration, 2) incremental plasma insulin response to meals, and 3) SSPG concentration, the more adverse the CHD risk profile (p<0.05). In contrast, the CHD risk profile did not significantly worsen with increases in the incremental plasma glucose response to meals. CONCLUSIONS In nondiabetic individuals, higher FPG concentrations, accentuated daylong incremental insulin responses to meals, and greater degrees of insulin resistance are each associated with worse CHD risk profile (higher blood pressures, higher triglycerides, and lower high density lipoprotein cholesterol concentrations). Interventional efforts aimed at decreasing CHD in such individuals should take these abnormalities into consideration.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D019518 Postprandial Period The time frame after a meal or FOOD INTAKE. Postcibal Period,Period, Postcibal,Period, Postprandial,Periods, Postcibal,Periods, Postprandial,Postcibal Periods,Postprandial Periods

Related Publications

Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
February 2015, Acta diabetologica,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
August 2012, Arteriosclerosis, thrombosis, and vascular biology,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
October 2005, Zhonghua nei ke za zhi,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
October 2017, Scientific reports,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
August 2017, Scientific reports,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
January 1991, Arteriosclerosis and thrombosis : a journal of vascular biology,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
July 2001, Metabolism: clinical and experimental,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
June 2007, Annals of internal medicine,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
December 2010, Diabetes care,
Shubha L Bhat, and Fahim A Abbasi, and Christine Blasey, and Gerald M Reaven, and Sun H Kim
September 2002, Journal of the American College of Cardiology,
Copied contents to your clipboard!